
Radio and PodcastLive Radio & Podcasts
Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch
In this episode of HealthTalk TV, we take a deep dive into the rapidly evolving treatment landscape of chronic lymphocytic leukemia (CLL). Host Lars Brock Nilsen is joined by Dr. Eugen Tausch, a leading international exp...
About This Episode
Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch is an episode from HealthTalk by Hans Anderssen. In this episode of HealthTalk TV, we take a deep dive into the rapidly evolving treatment landscape of chronic lymphocytic leukemia (CLL)....
This episode belongs to HealthTalk.
Use the player on this page to stream the episode online.
Published Apr 23, 2026, 25:58 long, audio available.
Questions About This Episode
What is Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch about?
In this episode of HealthTalk TV, we take a deep dive into the rapidly evolving treatment landscape of chronic lymphocytic leukemia (CLL). Host Lars Brock Nilsen is joined by Dr. Eugen Tausch, a leading international expert in CLL at the University Hospital in Ulm, to discuss how the field is moving away from chemotherapy and toward targeted, fixed-duration therapies — and what this means for patients in clinical practice. Together, they explore the key questions shaping CLL treatment today: how do you choose between continuous BTK inhibitor therapy and time-limited venetoclax-based combinations? What role should patient preferences play? And what does the latest clinical trial data tell us about the best strategy for different patient profiles? Topics covered in this episode: • What is CLL, and why is its course so heterogeneous? • The shift from chemoimmunotherapy to targeted therapies • BTK inhibitors vs. venetoclax-based combinations: how to choose • The importance of genetic risk factors (IGHV, TP53, del17p) • Patient involvement and shared decision-making • Key findings from the CLL17 trial • Treatment sequencing and managing relapse • Non-covalent BTK inhibitors and Pirtobrutinib: promise and open questions • What's on the horizon: BTK degraders, bispecifics, and CAR-T in CLL Dr. Tausch offers a nuanced and clinically grounded perspective on a field that continues to evolve at remarkable speed — and shares why he believes the best strategies are still being defined. Explore more from HealthTalk: – Read our news coverage: – Sign up for our newsletter: – Watch more interviews and broadcasts on YouTube –
Where can I listen to Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch?
You can listen to Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch from?
Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch is an episode from HealthTalk by Hans Anderssen.
How long is this episode?
This episode is 25:58 long.
When was this episode published?
This episode was published on Apr 23, 2026.
Can I save Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from HealthTalk?
Yes. This page shows related episodes from HealthTalk when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch?
You can listen to Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Chronic Lymphocytic Leukemia (CLL) with Eugen Tausch is from HealthTalk by Hans Anderssen.
What are the episode details?
Published Apr 23, 2026 and 25:58 long






